Inventor · disambiguated record
Mark Spaller
Also filed as: SPALLER MARK · SPALLER MARK R · SPALLER MARK ROBERT
8 granted patents·3 pending applications·20 citations·filing 2010–2024
82Inventor score
Files withDARTMOUTH COLLEGE4KING S COLLEGE LONDON3MUKHOPADHYAY DEBABRATA1NOELLE RANDOLPH J1SPALLER MARK1
Top patents by PatentIndex Score
11 records- 0194US10933115B2VISTA antagonist and methods of useKING S COLLEGE LONDON·Filed 2015·Granted Mar 2, 2021·10 cites·6 claims
- 0290US11752189B2Vista antagonist and methods of useDARTMOUTH COLLEGE·Filed 2019·Granted Sep 12, 2023·3 cites·17 claims
- 0372US12064463B2Vista antagonist and methods of useKING S COLLEGE LONDON·Filed 2021·Granted Aug 20, 2024·0 cites·11 claims
- 0470US10046024B2Cyclic-GluR6 analogs, methods of treatment and useUNIV BROWN·Filed 2016·Granted Aug 14, 2018·1 cites·7 claims
- 0569US9403876B2Cyclic-GluR6 analogs, methods of treatment and useSPALLER MARK·Filed 2010·Granted Aug 2, 2016·3 cites·22 claims
- 0667US2025114429A1Vista antagonist and methods of useKING S COLLEGE LONDON·Filed 2024·Application pending·0 cites
- 0765US2015231215A1VISTA Antagonist and Methods of UseNOELLE RANDOLPH J·Filed 2014·Application pending·0 cites
- 0864US9163063B2Peptides and nanoparticles for therapeutic and diagnostic applicationsDARTMOUTH COLLEGE·Filed 2013·Granted Oct 20, 2015·3 cites·12 claims
- 0954US2017165317A1Method for mitigating or alleviating synaptic and cognitive deficitsDARTMOUTH COLLEGE·Filed 2014·Application pending·0 cites
- 1048US8658601B2Peptides and nanoparticles for therapeutic and diagnostic applicationsMUKHOPADHYAY DEBABRATA·Filed 2011·Granted Feb 25, 2014·0 cites·4 claims
- 1136US10744180B2Therapy and kit for the prevention and treatment of cystic fibrosisDARTMOUTH COLLEGE·Filed 2017·Granted Aug 18, 2020·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →